These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9316555)

  • 1. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.
    Wheat J; MaWhinney S; Hafner R; McKinsey D; Chen D; Korzun A; Shakan KJ; Johnson P; Hamill R; Bamberger D; Pappas P; Stansell J; Koletar S; Squires K; Larsen RA; Cheung T; Hyslop N; Lai KK; Schneider D; Kauffman C; Saag M; Dismukes W; Powderly W
    Am J Med; 1997 Sep; 103(3):223-32. PubMed ID: 9316555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
    Wheat J; Hafner R; Wulfsohn M; Spencer P; Squires K; Powderly W; Wong B; Rinaldi M; Saag M; Hamill R; Murphy R; Connolly-Stringfield P; Briggs N; Owens S;
    Ann Intern Med; 1993 Apr; 118(8):610-6. PubMed ID: 8383934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.
    Wheat J; Hafner R; Korzun AH; Limjoco MT; Spencer P; Larsen RA; Hecht FM; Powderly W
    Am J Med; 1995 Apr; 98(4):336-42. PubMed ID: 7709945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.
    Hecht FM; Wheat J; Korzun AH; Hafner R; Skahan KJ; Larsen R; Limjoco MT; Simpson M; Schneider D; Keefer MC; Clark R; Lai KK; Jacobson JM; Squires K; Bartlett JA; Powderly W
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):100-7. PubMed ID: 9358104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome.
    Norris S; Wheat J; McKinsey D; Lancaster D; Katz B; Black J; Driks M; Baker R; Israel K; Traeger D
    Am J Med; 1994 Jun; 96(6):504-8. PubMed ID: 8017447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    McKinsey DS; Kauffman CA; Pappas PG; Cloud GA; Girard WM; Sharkey PK; Hamill RJ; Thomas CJ; Dismukes WE
    Clin Infect Dis; 1996 Nov; 23(5):996-1001. PubMed ID: 8922792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
    Wheat LJ; Connolly P; Smedema M; Brizendine E; Hafner R;
    Clin Infect Dis; 2001 Dec; 33(11):1910-3. PubMed ID: 11692303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
    Sharkey-Mathis PK; Velez J; Fetchick R; Graybill JR
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):809-19. PubMed ID: 8389850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histoplasmosis: update 1998.
    Brooks JT; Wheat LJ
    AIDS Clin Care; 1998 Jan; 10(1):4-5. PubMed ID: 11365076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
    Drew RH
    Ann Pharmacother; 1993 Dec; 27(12):1510-8. PubMed ID: 8305787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.
    Wheat LJ; Connolly P; Haddad N; Le Monte A; Brizendine E; Hafner R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):248-50. PubMed ID: 11751146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of HIV-associated cerebral histoplasmosis successfully treated with fluconazole.
    Knapp S; Turnherr M; Dekan G; Willinger B; Stingl G; Rieger A
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):658-61. PubMed ID: 10534189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histoplasmosis: not only a tropical disease].
    Bregani ER; Van Tien T; Ceraldi T; Delfitto C; Figini G
    Recenti Prog Med; 2000; 91(7-8):396-401. PubMed ID: 10932927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS).
    McKinsey DS; Gupta MR; Riddler SA; Driks MR; Smith DL; Kurtin PJ
    Ann Intern Med; 1989 Oct; 111(8):655-9. PubMed ID: 2802421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.
    Johnson PC; Wheat LJ; Cloud GA; Goldman M; Lancaster D; Bamberger DM; Powderly WG; Hafner R; Kauffman CA; Dismukes WE;
    Ann Intern Med; 2002 Jul; 137(2):105-9. PubMed ID: 12118965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
    De Wit S; O'Doherty E; De Vroey C; Clumeck N
    J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
    Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.